INTRODUCTION
Cirrhosis is defined histologically as a diffuse hepatic process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. The progression of liver injury to cirrhosis may occur over weeks to years. Indeed, patients with hepatitis C may have chronic hepatitis for as long as 40 years before progressing to cirrhosis [1] .
Portal hypertension is a progressive, inevitable consequence of liver cirrhosis, which leads to formation of portosystemic collateral veins. Among them, oesophageal varices have the greatest clinical impact because their rupture results in variceal hemorrhage that can be fatal. Upper gastrointestinal [GI) endoscopy is the gold standard in the diagnosis of oesophageal varices [2] .
Gastroesophageal varices are present in approximately 50% of patients with liver cirrhosis. Their presence correlates with the severity of liver disease. Patients without varices develop them at a rate of 8% per year and the progression from small to large varices occurs in 10 to 20% of cases yearly [3] . The most important predictor of hemorrhage is the size of varices, with the highest risk of first hemorrhage occurring in patients with large varices, about 15% per year [4] .
Practice guidelines have recommended that all patients with cirrhosis undergo screening upper GI endoscopy to detect oesophageal varices at the time of diagnosis and after that, surveillance endoscopies should be performed every 2 to 3 years in cirrhotic patients without varices and the patients with small varices be endoscoped every 1-2 years, and annually in the setting of decompensation [5] . However, these guidelines have not been evaluated prospectively to date ,particularly regarding its cost effectiveness. Since, the point prevalence of medium/large varices is approximately 15 to 20% [6], the majority of subjects undergoing screening endoscopy either do not have varices or have varices and do not require prophylactic therapy. Therefore, there is need for identification of non endoscopic, non invasive methods that can accurately predict oesophageal varices, particularly large ones in cirrhotic patients and help to identify patients at greatest risk and thereby reduce the necessity of endoscopic screening [7] .
In cirrhosis, the major portion of ammonia carried by portal blood is shunted by portosystemic collaterals into systemic circulation. The raised blood ammonia level may be an indicator of the presence of oesophageal varices as a main part of portosystemic shunts with the most dangerous complications [8).
On the other hand, a recent study found that there was a moderate but significant correlation between blood ammonia level and size of oesophageal varices [9] .
PATIENTS AND METHODS
This study was carried out on patients attending the outpatient clinic and the inpatients of Hepatology and Gastroenterology unit of Shebin Elkom Teaching Hospital in the period between June to December 2014, from which 60 cirrhotic patients were selected, in addition to 20 healthy persons of matched age and sex as controls. The cirrhotic patients were further subdivided into the two groups. Group Sample collection and measurement of ammonia Fasting blood ammonia level was measured in all patients and controls within 1 to 3 days of performing endoscopy. Patients were asked to fast overnight. In the morning, at complete rest, 5 ml of peripheral venous blood was taken from each subject without using tourniquet. Blood was collected into an EDTA evacuated tube. The samples were immediately carried to laboratory gently in an icebox and analyzed within 30 minutes of arrival. In cases of ambulant patient, samples were collected in the laboratory. During analysis, sample was first centrifuged and the plasma was separated from cellular material. Ammonia level was measured by kinetic enzymatic method with glutamate dehydrogenase by using ammonia-liquizyme single reagent provided by Bioassay system, Germany.
Statistical Analysis :
All the patient details and study variables were entered in predesigned data collection sheet. Data were analyzed by using statistical software SPSS 13.0. All the quantitative data were expressed as mean ± SD; qualitative data were analyzed by Chi-square test and quantitative data by Student's ttest or Mann-Whitney's U test. Correlation study was done by using Spearman's correlation coefficient test. Performance of the test was assessed by sensitivity and specificity. Receiver operating characteristic [ROC) curve was used to assess the usefulness of the test and performance at different cutoff values. A 'p' value of <0.05 was taken statistically significant and a 'p' value of <0.005 was taken highly statistically significant.
RESULTS
There was a high statistically significant difference between the mean values of blood ammonia level of cirrhotic patients and control group as shown in table (1) .
There was a high statistically significant increase in the mean values of blood ammonia in cirrhotic patients with varices in comparison to other patients without varices as shown in There was a high statistically significant positive correlation between blood ammonia and size of varices as shown in table (4) and figure (2), while there was a high statistically significant negative correlation between platelet count/ spleen diameter ratio and size of varices as shown in table (4).
There was a statistically significant decrease in the mean values of platelet count/spleen diameter ratio in cirrhotic patients with evidence of grade III and IV varices (large varices) in comparison to cirrhotic patients with grade I and II varices as shown in table (5) . The best cutoff value for detection of large varices was 436.5 with sensitivity 82.5%, specificity 70%, PPV 84.6% and NPV 66.7% as shown in table (6) .
There was a statistically significant increase in the mean values of blood ammonia in cirrhotic patients with evidence of grade III and IV varices (large varices) in comparison to cirrhotic patients with grade I and II varices as shown in table (5) . The best cutoff value was 102 umol/L with sensitivity of 95% and specificity of 52.5% in detecting large esophageal varices (grade III and IV varices) in patients with liver cirrhosis. Its PPV was 50% and NPV was 95.5% with accuracy of 66.7% as shown in table (6) and figure (3). The generated ammonia, which reaches the liver through the portal vein, is converted to urea by means of urea cycle and excreted from the kidneys. In patients with decreased hepatic functional reserve or those with portosystemic shunt, ammonia level in the blood rises [8].
This study was conducted to evaluate the role of blood ammonia as a non invasive marker for detection of oesophageal varices (O.V) and also for presence of large varices and compared it with platelet count/ spleen diameter ratio that is one of the most important non invasive predictors of O.V.
Blood ammonia values were estimated in cirrhotic groups and control group. The study showed that there was a highly significant difference between the mean ammonia level of cirrhotic and control groups (P<0.001 In the present study, there was a highly significant positive correlation between serum ammonia and size of varices, r (0.692) and P value (<0.001). This comes in agreement with study done by Khondaker et al.
[9] that found that there was a significant correlation between blood ammonia level and size of varices, r (0.451), P value (<0.05).
On the other hand, there was a significant negative correlation between platelet count/spleen diameter ratio and size of varices, r (-0.461) and P value (<0.05). This comes in agreement with study done by Thomopoulos et al. [18] that reported that there was negative correlation between platelet count/ spleen diameter ratio and size of varices, r (-0.431) and P value (<0.05).
In the present study, there was a significant decrease in the mean values of platelet count/spleen diameter ratio in cirrhotic patients with evidence of grade III and IV varices (large varices) in comparison to cirrhotic patients with grade I and II varices. 
